ArticleInflammopharmacology2024

Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers.

Pavlo Petakh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.